(The following appear in both Metabolic Daily and Glucose Control
doi:10.1039/B610682J Zhao W, Brook MA, Li Y (2008) Design of gold nanoparticlebased colorimetric biosensing assays
Alhusaini A, Sarawi W, Mattar D, Abo-Hamad A, Almogren R, Alhumaidan S, et al
Current pharmaceutical design , 20 (7), 1121-5
Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials
Introduction: Hypertension, commonly known as high blood pressure, is a prevalent condition that affects millions of people worldwide